Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mason, T. M.
Right arrow Articles by Giacca, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mason, T. M.
Right arrow Articles by Giacca, A.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 48, Issue 3 524-530, Copyright © 1999 by American Diabetes Association


ARTICLES

Prolonged elevation of plasma free fatty acids desensitizes the insulin secretory response to glucose in vivo in rats

TM Mason, T Goh, V Tchipashvili, H Sandhu, N Gupta, GF Lewis and A Giacca
Department of Physiology, University of Toronto, Ontario, Canada.

Prolonged exposure of pancreatic islets to free fatty acids (FFAs) inhibits glucose-stimulated insulin secretion (GSIS) in vitro. However, FFA inhibition of GSIS has not been clearly demonstrated in vivo. We examined the in vivo effect of prolonged elevation of plasma FFAs on GSIS using a two-step hyperglycemic clamp in rats treated with a 48-h intravenous infusion of either 20% Intralipid plus heparin (INT) (5 microl/min plus heparin, 0.1 U/min; n = 8), oleate (OLE) (1.3 microEq/min; n = 6), saline (SAL) (n = 6), or bovine serum albumin (BSA) (vehicle for OLE; n = 5). Because there was no difference in any of the parameters between BSA and SAL rats, these groups were combined as control rats (CONT) (n = 11). At the end of the 48-h OLE/INT/CONT infusions, after an overnight fast, plasma glucose was clamped for 2 h at 13 mmol/l and for another 2 h at 22 mmol/l. Preclamp plasma FFAs were elevated twofold (P < 0.01) versus CONT with both INT and OLE (NS, INT vs. OLE). Preclamp glucose, insulin, and C-peptide levels were higher in INT than in CONT rats (P < 0.05), suggesting insulin resistance, but they were not different in OLE and CONT rats. The insulin and C-peptide responses to the rise in plasma glucose from basal to 13 mmol/l were lower in OLE (336 +/- 72 pmol/l and 1.2 +/- 0.1 nmol/l, P < 0.01 and P < 0.05, respectively) than in CONT (552 +/- 54 and 1.9 +/- 0.1) rats, but they were not different between CONT and INT rats (648 +/- 150 and 2.0 +/- 0.4). The insulin and C-peptide responses to the rise in plasma glucose from 13 to 22 mmol/l were lower in both INT (1,188 +/- 204 pmol/l and 3.0 +/- 0.3 nmol/l, P < 0.01 and P < 0.001) and OLE (432 +/- 60 and 1.7 +/- 0.2, P < 0.001 vs. CONT or INT) rats than in CONT rats (1,662 +/- 174 and 5.0 +/- 0.6). In summary, 1) both INT and OLE decreased GSIS in vivo in rats, and 2) the impairing effect of INT on GSIS was less than that of OLE, which might be due to the different type of fatty acid (mostly polyunsaturated in INT versus monounsaturated as OLE) and/or to differential effects of INT and OLE on insulin sensitivity. In conclusion, prolonged elevation of plasma FFAs can desensitize the insulin secretory response to glucose in vivo, thus inducing a beta-cell defect that is similar to that found in type 2 diabetes.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
D. K. Hagman, M. G. Latour, S. K. Chakrabarti, G. Fontes, J. Amyot, C. Tremblay, M. Semache, J. A. Lausier, V. Roskens, R. G. Mirmira, et al.
Cyclical and Alternating Infusions of Glucose and Intralipid in Rats Inhibit Insulin Gene Expression and Pdx-1 Binding in Islets
Diabetes, February 1, 2008; 57(2): 424 - 431.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. I. Oprescu, G. Bikopoulos, A. Naassan, E. M. Allister, C. Tang, E. Park, H. Uchino, G. F. Lewis, I. G. Fantus, M. Rozakis-Adcock, et al.
Free Fatty Acid Induced Reduction in Glucose-Stimulated Insulin Secretion: Evidence for a Role of Oxidative Stress In Vitro and In Vivo
Diabetes, December 1, 2007; 56(12): 2927 - 2937.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
C. Tang, P. Han, A. I. Oprescu, S. C. Lee, A. V. Gyulkhandanyan, G. N.Y. Chan, M. B. Wheeler, and A. Giacca
Evidence for a Role of Superoxide Generation in Glucose-Induced {beta}-Cell Dysfunction In Vivo
Diabetes, November 1, 2007; 56(11): 2722 - 2731.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. Fujiwara, F. Maekawa, K. Dezaki, M. Nakata, T. Yashiro, and T. Yada
Oleic Acid Glucose-Independently Stimulates Glucagon Secretion by Increasing Cytoplasmic Ca2+ via Endoplasmic Reticulum Ca2+ Release and Ca2+ Influx in the Rat Islet {alpha}-Cells
Endocrinology, May 1, 2007; 148(5): 2496 - 2504.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
T. T. Goh, T. M. Mason, N. Gupta, A. So, T. K. T. Lam, L. Lam, G. F. Lewis, A. Mari, and A. Giacca
Lipid-induced beta-cell dysfunction in vivo in models of progressive beta-cell failure
Am J Physiol Endocrinol Metab, February 1, 2007; 292(2): E549 - E560.
[Abstract] [Full Text] [PDF]


Home page
J DAIRY SCIHome page
S. Oikawa and G. R. Oetzel
Decreased insulin response in dairy cows following a four-day fast to induce hepatic lipidosis.
J Dairy Sci, August 1, 2006; 89(8): 2999 - 3005.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
H. Yoshii, T. K. T. Lam, N. Gupta, T. Goh, C. A. Haber, H. Uchino, T. T. Y. Kim, V. Z. Chong, K. Shah, I. G. Fantus, et al.
Effects of portal free fatty acid elevation on insulin clearance and hepatic glucose flux
Am J Physiol Endocrinol Metab, June 1, 2006; 290(6): E1089 - E1097.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
M. D. Jensen
Adipose tissue as an endocrine organ: implications of its distribution on free fatty acid metabolism
Eur. Heart J. Suppl., May 1, 2006; 8(suppl_B): B13 - B19.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
E. C. Eringa, C. D. A. Stehouwer, K. Walburg, A. D. Clark, G. P. van Nieuw Amerongen, N. Westerhof, and P. Sipkema
Physiological Concentrations of Insulin Induce Endothelin-Dependent Vasoconstriction of Skeletal Muscle Resistance Arteries in the Presence of Tumor Necrosis Factor-{alpha} Dependence on c-Jun N-Terminal Kinase
Arterioscler. Thromb. Vasc. Biol., February 1, 2006; 26(2): 274 - 280.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
J L M R Leroy, T Vanholder, B Mateusen, A Christophe, G Opsomer, A de Kruif, G Genicot, and A Van Soom
Non-esterified fatty acids in follicular fluid of dairy cows and their effect on developmental capacity of bovine oocytes in vitro
Reproduction, October 1, 2005; 130(4): 485 - 495.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
K. Fujiwara, F. Maekawa, and T. Yada
Oleic acid interacts with GPR40 to induce Ca2+ signaling in rat islet {beta}-cells: mediation by PLC and L-type Ca2+ channel and link to insulin release
Am J Physiol Endocrinol Metab, October 1, 2005; 289(4): E670 - E677.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. C. Eringa, C. D. A. Stehouwer, G. P. van Nieuw Amerongen, L. Ouwehand, N. Westerhof, and P. Sipkema
Vasoconstrictor effects of insulin in skeletal muscle arterioles are mediated by ERK1/2 activation in endothelium
Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H2043 - H2048.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. Bays, L. Mandarino, and R. A. DeFronzo
Role of the Adipocyte, Free Fatty Acids, and Ectopic Fat in Pathogenesis of Type 2 Diabetes Mellitus: Peroxisomal Proliferator-Activated Receptor Agonists Provide a Rational Therapeutic Approach
J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 463 - 478.
[Full Text] [PDF]


Home page
DiabetesHome page
M. C. Sugden and M. J. Holness
Potential Role of Peroxisome Proliferator-Activated Receptor-{alpha} in the Modulation of Glucose-Stimulated Insulin Secretion
Diabetes, February 1, 2004; 53(90001): S71 - 81.
[Abstract] [Full Text]


Home page
DiabetesHome page
R. P. Robertson, J. Harmon, P. O. T. Tran, and V. Poitout
{beta}-Cell Glucose Toxicity, Lipotoxicity, and Chronic Oxidative Stress in Type 2 Diabetes
Diabetes, February 1, 2004; 53(90001): S119 - 124.
[Abstract] [Full Text]


Home page
DiabetesHome page
A. Carpentier, B. Zinman, N. Leung, A. Giacca, A. J.G. Hanley, S. B. Harris, R. A. Hegele, and G. F. Lewis
Free Fatty Acid-Mediated Impairment of Glucose-Stimulated Insulin Secretion in Nondiabetic Oji-Cree Individuals From the Sandy Lake Community of Ontario, Canada: A Population at Very High Risk for Developing Type 2 Diabetes
Diabetes, June 1, 2003; 52(6): 1485 - 1495.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. Prentki, E. Joly, W. El-Assaad, and R. Roduit
Malonyl-CoA Signaling, Lipid Partitioning, and Glucolipotoxicity: Role in {beta}-Cell Adaptation and Failure in the Etiology of Diabetes
Diabetes, December 1, 2002; 51(90003): S405 - 413.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. L. Dobbins, L. S. Szczepaniak, J. Myhill, Y. Tamura, H. Uchino, A. Giacca, and J. D. McGarry
The Composition of Dietary Fat Directly Influences Glucose-Stimulated Insulin Secretion in Rats
Diabetes, June 1, 2002; 51(6): 1825 - 1833.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
G. F. Lewis, A. Carpentier, K. Adeli, and A. Giacca
Disordered Fat Storage and Mobilization in the Pathogenesis of Insulin Resistance and Type 2 Diabetes
Endocr. Rev., April 1, 2002; 23(2): 201 - 229.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
G. M. Steil, N. Trivedi, J.-C. Jonas, W. M. Hasenkamp, A. Sharma, S. Bonner-Weir, and G. C. Weir
Adaptation of {beta}-cell mass to substrate oversupply: enhanced function with normal gene expression
Am J Physiol Endocrinol Metab, May 1, 2001; 280(5): E788 - E796.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
M. Blüher, J. Kratzsch, and R. Paschke
Plasma Levels of Tumor Necrosis Factor-{alpha}, Angiotensin II, Growth Hormone, and IGF-I Are Not Elevated in Insulin-Resistant Obese Individuals With Impaired Glucose Tolerance
Diabetes Care, February 1, 2001; 24(2): 328 - 334.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
K. T. Uysal, L. Scheja, S. M. Wiesbrock, S. Bonner-Weir, and G. S. Hotamisligil
Improved Glucose and Lipid Metabolism in Genetically Obese Mice Lacking aP2
Endocrinology, September 1, 2000; 141(9): 3388 - 3396.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. Carpentier, S. D. Mittelman, R. N. Bergman, A. Giacca, and G. F. Lewis
Acute enhancement of insulin secretion by FFA in humans is lost with prolonged FFA elevation
Am J Physiol Endocrinol Metab, June 1, 1999; 276(6): E1055 - E1066.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1999 by the American Diabetes Association.